Trusted Manufacturer and Exporter of Bedaquiline Tablets 100mg (Hamsen)

When it comes to Bedaquiline Tablets 100mg (Hamsen) manufacturers in India, Taj Pharma India stands as a globally recognized and trusted name. With a commitment to quality, purity, and affordability, Taj Pharmaceuticals has emerged as a leading manufacturer, exporter, and supplier of Bedaquiline Tablets used in the treatment of multidrug-resistant tuberculosis (MDR-TB).

As a WHO-GMP, ISO-certified, and regulatory-compliant pharmaceutical company headquartered in Vapi, Gujarat, India, Taj Pharma has earned its reputation as a pioneer in anti-TB medicines. Our Bedaquiline Tablets 100mg are manufactured under stringent international standards, making them widely preferred across India, Africa, the Middle East, and Latin America (LTAM).

What is Bedaquiline Tablets 100mg (Hamsen)?

Bedaquiline is an antibiotic used as part of a combination therapy to treat pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis that is resistant to first-line anti-TB drugs. By inhibiting ATP synthase, an enzyme essential for the energy production of TB bacteria, Bedaquiline effectively kills resistant strains of Mycobacterium.

• Strength: 100mg
• Dosage Form: Film-coated Tablets
• Therapeutic Class: Anti-tuberculosis agent
• Brand Name: Hamsen (by Taj Pharma)

This revolutionary treatment has provided new hope for patients battling MDR-TB, where traditional medications fail.

Leading Manufacturer of Bedaquiline Tablets 100mg

Taj Pharmaceuticals ensures world-class pharmaceutical manufacturing through advanced facilities and cutting-edge technology. Our state-of-the-art plants in Vapi, Gujarat, comply with USFDA, WHO-GMP, and EU standards.

We are among the top Bedaquiline Tablets 100mg manufacturers in India, supplying high-quality products at competitive prices. Our medicines are trusted by hospitals, NGOs, government health programs, and global procurement agencies.

Key Highlights:

• PAN India supply chain network
• Exports to Africa, Middle East, Latin America
• WHO-prequalified and regulatory-compliant
• Bulk availability for tenders, PCD franchise, and contract manufacturing

Therapeutic Indications of Bedaquiline Tablets 100mg

Bedaquiline is prescribed as part of a combination regimen for:

• Pulmonary multidrug-resistant tuberculosis (MDR-TB)
• Cases where TB bacteria are resistant to isoniazid and rifampicin
• Patients requiring advanced therapy when conventional treatment fails

Important Note: Bedaquiline should always be taken in combination with other anti-TB drugs to avoid resistance development.

Cautions & Warnings

While Bedaquiline Tablets 100mg are highly effective, certain precautions must be followed:

• QT Prolongation Risk: Bedaquiline may cause irregular heart rhythms. Patients should undergo ECG monitoring.
• Liver Monitoring: Regular liver function tests (LFTs) are required, as Bedaquiline may elevate liver enzymes.
• Alcohol & Drug Interactions: Avoid alcohol and interacting medications to minimize side effects.
• Medical Supervision Required: Should only be prescribed and monitored by specialized TB treatment centers.

Adverse Effects May Include:

• Dizziness, headache
• Chest pain, palpitations
• Gastrointestinal disturbances
• Fainting in rare cases

Storage & Dosage Information

• Storage: Store below 30°C, in a cool, dry place, away from light and moisture.
• Dosage: Typically administered as 400mg once daily for the first 2 weeks, followed by 200mg three times per week for 22 weeks (in combination therapy).
• Administration: Take with food for better absorption.

Important: Dosage should strictly follow physician’s prescription and national TB guidelines.

Technical Specification of Bedaquiline Tablets 100mg (Hamsen)

• Generic Name: Bedaquiline Tablets
• Brand Name: Hamsen
• Strength: 100mg
• Dosage Form: Film-coated Tablet
• Route of Administration: Oral
• Packing: Blister strips / bottles as per requirement
• Pack Insert/Leaflet: Available with dosage guidelines
• Regulatory Documents: COA, MSDS, WHO-GMP, ISO certificates
• Therapeutic Use: MDR-TB treatment
• Indication: For patients resistant to conventional TB drugs
• Storage Condition: Below 30°C, protected from moisture
• Shelf Life: 24 months from manufacturing date

Global Supply & Export of Bedaquiline Tablets 100mg

Taj Pharma India is a trusted global exporter of Bedaquiline Tablets with a strong distribution network in:

• Africa: Nigeria, Kenya, South Africa, Ethiopia, Uganda
• Middle East: UAE, Saudi Arabia, Oman, Yemen
• Latin America (LTAM): Brazil, Mexico, Argentina, Chile
• Asia-Pacific: Sri Lanka, Philippines, Vietnam, Bangladesh

Our pharmaceutical exports are supported by regulatory documentation, making us a preferred supplier for government tenders, NGOs, and international aid programs.

Bedaquiline Tablets Supplier and PCD Pharma Franchise in India

Taj Pharma India offers lucrative opportunities for:

• PCD Pharma Franchise Partners across India
• Bulk suppliers and distributors seeking MDR-TB medicines
• Hospital procurement teams and NGOs
• International buyers and importers seeking WHO-GMP-certified medicines

Our Bedaquiline Tablets 100mg are supplied at the best industry prices while maintaining uncompromised quality.

Why Choose Taj Pharma India for Bedaquiline Tablets 100mg?

• WHO-GMP and ISO certified facilities
• PAN India distribution and global exports
• Competitive pricing for government tenders & NGOs
• High purity, efficacy, and patient safety standards
• Regulatory support and technical documents provided
• Trusted by hospitals, health ministries, and TB programs worldwide

With years of expertise in anti-tuberculosis drug manufacturing, we remain a leading choice for Bedaquiline Tablets suppliers and exporters in India.

Taj Pharma India is recognized as the #1 Bedaquiline Tablets 100mg (Hamsen) manufacturer in India, with a reputation built on trust, compliance, and global supply excellence. As a company dedicated to fighting multidrug-resistant tuberculosis, we ensure that patients worldwide gain access to safe, effective, and affordable Bedaquiline therapy.